What is the difference between Cerebrolysin and TRH?

Cerebrolysin: Standardized mixture of neuropeptides derived from porcine brain proteins; mimics endogenous neurotrophic factors (BDNF, NGF, CNTF); promotes neurogenesis and synaptic plasticity TRH: Hypothalamic tripeptide (pGlu-His-Pro-NH2); binds TRH-R1/R2; stimulates TSH/prolactin release; direct CNS effects independent of thyroid axis including synaptic potentiation

Is Cerebrolysin FDA approved?

Cerebrolysin is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

TRH is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cerebrolysin administered in research settings?

In research settings, Cerebrolysin is typically administered via the intravenous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

How is TRH administered in research settings?

In research settings, TRH is typically administered via the intranasal, intravenous, or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cerebrolysin vs TRH

Peptide Comparison

Cerebrolysin vs TRH

Name: Cerebrolysin vs TRH — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Neuro & Cognitive peptides.

Cerebrolysin

FPF 1070

CognitiveInvestigationalResearch Only

Half-life: Varies by component

32 providers listed

Full Cerebrolysin profile →

TRH

Thyrotropin-Releasing Hormone

CognitiveNot EvaluatedCompoundable

Half-life: ~5-6 minutes

3 providers listed

Full TRH profile →

Bottom line

Cerebrolysin carries stronger published evidence (Meta-analysis, 5 key studies) than TRH (RCT, 2); both are research compounds.

Quick Verdict

Cerebrolysin

Evidence

Established Clinical

Half-life

Varies by component

TRH

Evidence

Emerging Clinical

Half-life

~5-6 minutes

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Cerebrolysin
Further along in FDA review	Cerebrolysin
More provider options (32 vs 3)	Cerebrolysin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cerebrolysin

TRH

Mechanism Family

Neuro & Cognitive

Half-life

Varies by component

~5-6 minutes

FDA Status

investigational

not evaluated

Admin Routes

intravenous, intramuscular

intranasal, intravenous, subcutaneous

Availability

Research Only

Compoundable

Providers

32 listed

3 listed

Avail. Notes

Neuropeptide mixture approved in EU/Asia but NOT FDA-approved. Phase 2/3 US trials for Alzheimer's disease and stroke with active IND. No NDA filed. Research use in US.

Was FDA-approved as Thypinone (NDA 017812) and Relefact TRH for diagnostic TSH testing. Both products voluntarily discontinued. Nominated on the FDA 503B outsourcing-facility list (Category 3 — nominated without adequate support to date); not on the 503A pharmacy bulk-substances list. Prescription.

Research Evidence

Cerebrolysin

Established ClinicalMeta-analysis · 5 key studies · most recent 2026

TRH

Emerging ClinicalRCT · 2 key studies · dated evidence base — most recent 1997

Research Citations

Cerebrolysin

Cohort2026 · Cells

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothel…

Cohort2026 · Biomolecules

Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the Helix pomatia-Snail Model of Lear…

Cohort2026 · Asian J Neurosurg

Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Mon…

RCT2024 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a thre…

+1 more

TRH

Animal1997 · Regulatory Peptides

Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice followi…

RCT1990 · Psychopharmacology

TRH attenuates scopolamine-induced memory impairment in humans

About Cerebrolysin

Standardized mixture of neuropeptides derived from porcine brain proteins; mimics endogenous neurotrophic factors (BDNF, NGF, CNTF); promotes neurogenesis and synaptic plasticity

Research Areas

neuroprotectionneuroplasticitymemory improvementcognitive recovery

About TRH

Hypothalamic tripeptide (pGlu-His-Pro-NH2); binds TRH-R1/R2; stimulates TSH/prolactin release; direct CNS effects independent of thyroid axis including synaptic potentiation

Research Areas

cognitive enhancementneuroprotectionantidepressantarousal/wakefulness

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerebrolysin

Reported (Unverified — Pending Clinical Review)

epilepsyrenal failureporcine protein allergy

No established clinical contraindications

TRH

Reported (Unverified — Pending Clinical Review)

hyperthyroidismcardiac arrhythmiashypertensionepilepsy

No established clinical contraindications

Price (per mg)

Cerebrolysin

$1.12/mg

$1.05 – $1.78 range

6 vendors

View price index →Find providers →

TRH

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

Cerebrolysin

32 listed

Browse directory →

Providers offering

TRH

3 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerebrolysin vs TRH — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/cerebrolysin/trh

https://peptidebase.io/peptides/compare/cerebrolysin/trh Methodology License Download JSON Download CSV